EI- Nile Co. for Pharmaceuticals and Chemical Industries Stock
Equities
NIPH
EGS38331C012
Pharmaceuticals
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
69.06 EGP | 0.00% |
|
0.00% | -16.90% |
Sales 2022 | 877M 18.27M | Sales 2023 | 1.01B 20.94M | Capitalization | 405M 8.44M |
---|---|---|---|---|---|
Net income 2022 | 89M 1.85M | Net income 2023 | 119M 2.48M | EV / Sales 2022 | 0.44 x |
Net Debt 2022 | 26.21M 546K | Net Debt 2023 | 191M 3.98M | EV / Sales 2023 | 0.59 x |
P/E ratio 2022 |
4
x | P/E ratio 2023 |
3.4
x | Employees | - |
Yield 2022 |
8.38% | Yield 2023 |
12.5% | Free-Float | 21.83% |
1 month | +0.45% | ||
3 months | -15.61% | ||
6 months | -16.90% | ||
Current year | -16.90% |
![Extreme 68.55](/images/extremecours_fleche.png)
![Extreme 65.02](/images/extremecours_fleche.png)
![Extreme 65.02](/images/extremecours_fleche.png)
![Extreme 37](/images/extremecours_fleche.png)
![Extreme 24](/images/extremecours_fleche.png)
![Extreme 15.7](/images/extremecours_fleche.png)
![Extreme 7.72](/images/extremecours_fleche.png)
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | - | |
Director of Finance/CFO | - | - | |
Investor Relations Contact | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | - | - | |
Chairman | - | - | |
Director/Board Member | - | - |
Date | Price | Change | Volume |
---|---|---|---|
24-07-07 | 69.06 | 0.00% | 1,321 |
24-07-04 | 69.06 | 0.00% | 37 |
24-07-03 | 69.06 | 0.00% | 691 |
24-07-02 | 69.06 | 0.00% | 343 |
24-07-01 | 69.06 | 0.00% | 1,250 |
End-of-day quote Egyptian Exchange, July 03, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
-16.90% | 14.57M | |
+56.89% | 823B | |
+39.52% | 627B | |
-6.55% | 353B | |
+15.99% | 320B | |
+7.92% | 295B | |
+13.74% | 239B | |
+13.83% | 220B | |
-0.49% | 219B | |
+7.94% | 167B |
- Stock Market
- Equities
- NIPH Stock